Literature DB >> 32516898

Significance and Diagnostic Accuracy of Early S100B Serum Concentration after Aneurysmal Subarachnoid Hemorrhage.

Baptiste Balança1,2,3, Thomas Ritzenthaler1, Florent Gobert1, Caroline Richet4, Carole Bodonian1, Romain Carrillon1, Anne Terrier1, Laurent Desmurs4, Armand Perret-Liaudet4,5, Frédéric Dailler1.   

Abstract

BACKGROUND: Early brain injuries (EBI) are one of the most important causes of morbidity and mortality after subarachnoid hemorrhage. At admission, a third of patients are unconscious (spontaneously or sedated) and EBI consequences are not evaluable. To date, it is unclear who will still be comatose (with severe EBI) and who will recover (with less severe EBI) once the aneurysm is treated and sedation withdrawn. The objective of the present study was to determine the diagnostic accuracy of S100B levels at hospital admission to identify patients with severe neurological consequences of EBI.
METHODS: Patients were consecutively included in this prospective blinded observational study. A motor component of the Glasgow coma score under 6 on day 3 was used to define patients with severe neurological consequences of EBI.
RESULTS: A total of 81 patients were included: 25 patients were unconscious at admission, 68 were treated by coiling. On day 3, 12 patients had severe consequences of EBI. A maximal S100B value between admission and day 1 had an area under the receiver operating characteristic curve (AUC) of 86.7% to predict severe EBI consequences. In patients with impaired consciousness at admission, the AUC was 88.2%.
CONCLUSION: Early S100B seems to have a good diagnostic value to predict severe EBI. Before claiming the usefulness of S100B as a surrogate marker of EBI severity to start earlier multimodal monitoring, these results must be confirmed in an independent validation cohort.

Entities:  

Keywords:  S100B protein; early brain injury; patient outcome assessment; subarachnoid hemorrhage

Year:  2020        PMID: 32516898     DOI: 10.3390/jcm9061746

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  2 in total

Review 1.  DAMPs and RAGE Pathophysiology at the Acute Phase of Brain Injury: An Overview.

Authors:  Baptiste Balança; Laurent Desmurs; Jérémy Grelier; Armand Perret-Liaudet; Anne-Claire Lukaszewicz
Journal:  Int J Mol Sci       Date:  2021-02-28       Impact factor: 5.923

2.  Brain-Specific Biomarkers as Mortality Predictors after Aneurysmal Subarachnoid Haemorrhage.

Authors:  Jaroslaw Kedziora; Malgorzata Burzynska; Waldemar Gozdzik; Andrzej Kübler; Agnieszka Uryga; Magdalena Kasprowicz; Barbara Adamik
Journal:  J Clin Med       Date:  2020-12-20       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.